Immunologic Responses After COVID-19 Vaccination in Patients With Membranous Nephropathy Receiving Anti–CD38 Felzartamab Therapy: Results From the Phase 1b/2a M-PLACE Study
Kidney International Reports（2022）
关键词
anti-CD38 antibody,anti-SARS-CoV-2 antibody response,COVID-19 vaccination,felzartamab (MOR202/TJ202),membranous nephropathy,plasma cell depletion
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要